
基本信息:
- 专利标题: 一种粪便样本中菌群稳态评价方法及在结直肠癌筛查中的应用
- 专利标题(英):Method for evaluating stable state of flora in excrement sample and application of method in colorectal cancer screening
- 申请号:CN201711119759.1 申请日:2017-10-31
- 公开(公告)号:CN108690864A 公开(公告)日:2018-10-23
- 发明人: 张革 , 郭松鹤 , 陆永帆 , 刘万里
- 申请人: 中山大学
- 申请人地址: 广东省广州市番禺区广州大学城外环东路132号中山大学
- 专利权人: 中山大学
- 当前专利权人: 中山大学
- 当前专利权人地址: 广东省广州市番禺区广州大学城外环东路132号中山大学
- 主分类号: C12Q1/04
- IPC分类号: C12Q1/04 ; C12R1/01
The invention relates to a method for calculating a flora balanced relation index in an individual excrement sample, and an application of the method in screening, diagnosis or auxiliary diagnosis incolorectal cancer (CRC). By extracting bacteria in excrement during DNA sequencing, the types and quantity characteristics of the bacteria can be obtained, and a CRC diagnosis by taking quantity ratiocharacteristic of a plurality of bacteria as a base is carried out. Compared with the methods used in clinical diagnosis or noninvasive screening of CRC with an applied patent, the method is completely noninvasive, and can realize accurate diagnosis of CRC. The analysis result displays that a ratio of fusobacterium nucleatum Fn to bifidobacteria Bb quantity (Fn/Bb) has high susceptibility and specificity on CRC screening, which can respectively reach 84.6% and 92.3% (AUC=0.911). the ratio of fusobacterium nucleatum Fn to clostridium leptum Fp (Fn/Fp) quantity is combined to increase the diagnosis value on CRC, and the Area Under Curve (AUC) of a subject work characteristic curve can reach 0.943. In addition, combination of Fn/Bb and Fn/Fp quantity ratio for screening I-stage CRC has 60% of specificity and 90% of sensitivity.